PLASMABLASTIC LYMPHOMA
Clinical trials for PLASMABLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PLASMABLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for PLASMABLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for HIV patients battling aggressive lymphoma
Disease control Recruiting nowThis early-stage study is testing whether adding the drug pomalidomide to standard chemotherapy (with or without rituximab) is safe and tolerable for adults with HIV and aggressive B-cell lymphomas. The main goal is to find the highest dose that doesn't cause severe side effects.…
Matched conditions: PLASMABLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for aggressive lymphoma patients Who've run out of options
Disease control Recruiting nowThis study is testing whether adding the drug daratumumab to two existing medications (bortezomib and dexamethasone) can help control plasmablastic lymphoma that has returned or hasn't responded to previous treatments. The trial will enroll about 28 adults whose cancer cells show…
Matched conditions: PLASMABLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New pill tested for Tough-to-Treat blood cancers
Disease control Recruiting nowThis is a first-in-human study to test the safety of a new oral drug called SGR-1505 in adults with various types of relapsed or hard-to-treat B-cell cancers, like non-Hodgkin lymphoma and chronic lymphocytic leukemia. The main goal is to find the highest dose patients can tolera…
Matched conditions: PLASMABLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Global hunt for clues in rare blood cancer
Knowledge-focused Recruiting nowThis study aims to better understand plasmablastic lymphoma, a rare type of blood cancer, by looking back at the medical records of 200 past patients. Researchers will collect information on how patients were diagnosed, what treatments they received, and how they fared over time.…
Matched conditions: PLASMABLASTIC LYMPHOMA
Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC